{"nct_id":"NCT05213728","title":"A Phase 1, Open-label, Safety and Immunogenicity Study of an Oral Multi-dose Administration Regimen With an Adenoviral-vector Based Tablet Norovirus Vaccine (VXA-G1.1-NN) Administered to Healthy Adult Volunteers","status":"COMPLETED","status_verified_date":"2022-09","start_date":"2022-01-24","start_date_type":"ACTUAL","primary_completion_date":"2022-02-01","primary_completion_date_type":"ACTUAL","completion_date":"2022-02-24","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["VXRT"]}